Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Precision-T: A Randomized Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic MalignanciesHemic and Lymphatic Diseases, Neoplasms by Histologic Type, Precursor Cell Lymphoblastic Leukemia-Lymphoma, acute biphenotypic leukemia, acute leukemia, acute myeloid leukemia, bone marrow disorder, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, mixed phenotype acute leukemia, myelodysplastic syndrome, myeloid leukemia, neoplasmActive, not recruitingPhase 32026-03-04NCT05316701

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Orca Biosystems, Inc.8

19 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
City of HopeDuarteUnited States238
Cleveland ClinicClevelandUnited States558
Colorado Blood Cancer InstituteDenverUnited States178
Massachusetts General HospitalBostonUnited States1015
Memorial Sloan Kettering Cancer CenterNew YorkUnited States1000
Moffitt Cancer CenterTampaUnited States523
Oregon Health & Sciences University - Knight Cancer InstitutePortlandUnited States2
OU Health Stephenson Cancer CenterOklahoma CityUnited States23
Ronald Reagan UCLA Medical CenterLos AngelesUnited States41
Sarah Cannon Research InstituteNashvilleUnited States1
Stanford Health CareStanfordUnited States20
UC DavisSacramentoUnited States25
University of ChicagoChicagoUnited States312
University of Miami Hospital and Clinics - Sylvester Comprehensive Cancer CenterMiamiUnited States3
University of Michigan Health System - Michigan MedicineAnn ArborUnited States2
University of UtahSalt Lake CityUnited States137
Vanderbilt UniversityNashvilleUnited States51
Weill Cornell Medicine - New York-Presbyterian HospitalNew YorkUnited States2
Winship Cancer Institute - Emory UniversityAtlantaUnited States6